Table 5.

Randomized control trials comparing PRP to local steroid injection for plantar fasciitis.

Study	Sample size		Steroid preparation	PRP volume (ml)	Maximal follow-up (months)	Outcome measure	Superior outcomes	Complications
	PRP	steroid						PRP	Steroid
Omar et al., 2012	15	15	NS	NS	1	VAS, DASH, FHSQ	PRP	0	0
Tiwari and Bhargava 2013	30	30	40 methylprednisolone	5	6	VAS	PRP	NS	NS
Monto 2014	20	20	40 methylprednisolone	3	24	AOFAS	PRP	NS	NS
Sherpy et al., 2016	25	25	80 triamcinolone	3	3	VAS	Comparable	0	0
Jain et al., 2015	30	30	40 triamcinolone	2.5	12	VAS, AOFAS	PRP	NS	NS
Acosta-Olivo et al., 2017	14	14	8 mg Dexamethasone	3	4	VAS, AOFAS, FADI	Comparable	0	0
Mahindra et al., 2016	25	25	80 methylprednisolone	3	3	VAS, AOFAS	Comparable	NS	NS
Vahdatpour et al., 2016	16	16	40 methylprednisolone	3	6	VAS, RMS, Sonography	PRP	NS	NS
Ugurlar et al., 2018	39	40	40 betamethasone	5	36	VAS	Comparable	NS	NS
Jain et al., 2018	40	30	80 methylprednisolone	3	6	VAS, AOFAS, Sonography	Comparable	NS	NS
Shetty et al., 2019	30	30	80 methylprednisolone	2	18	VAS, RMS	PRP	NS	NS
PRESENT STUDY	58	60	80 methylprednisolone	2	6	VAS, AOFAS	PRP	0	0

NS=Not Specified.